Vaccine Sales Plummet But Are Expected To “Rebound Later This Year”

by Mac Slavo | Apr 23, 2022 | Headline News | 17 comments

[dipl_text_animator animated_text=”Do you LOVE America? | Do you WANT our borders secured? | Don’t miss on the latest news | Subscribe and stay informed!” animation_layout=”zoom” animation_time=”740ms” animation_hold=”5010ms” _builder_version=”4.24.0″ _module_preset=”default” global_text_settings_text_align=”center” global_text_settings_text_color=”#FFFFFF” global_colors_info=”{}”][/dipl_text_animator]
[contact-form-7 id=”6521033″ title=”Article Subscribe”]

Share

People have had enough of the injections and vaccine sales have plummeted. But big pharma’s sales of the “vaccines” are expected to “rebound later this year.” We all know what that means…

Fierce Pharma warned that when Johnson & Johnson said Tuesday that it would not project COVID-19 vaccine sales for this year, citing a “global supply surplus” and “vaccine hesitancy,” the news sent a rumble through Wall Street that COVID vaccine sales could drop considerably this year as the world tries to shift from the pandemic to an endemic stage. But the ruling class has something up their sleeves because the “experts” are expecting vaccine sales to “rebound later this year.”

Are they planning to “release” or propagate another variant that you’ll need a shot for? Perhaps. Only time will tell. Maybe they just hope that the “renewed” spread of the virus will occur again in the fall and the rulers will be able to convince people to get another booster shot.

Cantor Fitzgerald’s faith in the durability of the COVID vaccine market was further bolstered by the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) meeting Wednesday, which highlighted the potential for renewed spread of the virus in the fall and winter along with an increased need for booster shots.

“Additional boosters in the fall/winter could represent upside to estimates as well,” Louise Chen wrote in a note to clients.

FirecePharma

Analysts at Cantor Fitzgerald believe that the assumption that vaccine sales will diminish may be premature. “It’s too early to call,” Chen wrote. “It does look like the phasing of vaccine sales this year could be back-end loaded. We expect more focused discussions to take place on the need/framework for additional booster doses ahead of a potential fall/winter surge,” the analysts wrote.

Are they alerting people to the possibility of more variants or a “surge” that will require another injection in the fall? Again, maybe. But it’s too early to tell what exactly is in store for us down the road. Whatever it is, it will include more injections of the mRNA toxic sauce.

[the_ad_group id=”24571″]

URGENT ON GOLD… as in URGENT

It Took 22 Years to Get to This Point

Gold has been the right asset with which to save your funds in this millennium that began 23 years ago.

Free Exclusive Report

The inevitable Breakout – The two w’s

[email-download download_id=”345496″ contact_form_id=”19fc5e7″]

Related Articles

[the_ad_group id=”30340″]

Comments

Join the conversation!

It’s 100% free and your personal information will never be sold or shared online.

0 Comments

Submit a Comment

Commenting Policy:

Some comments on this web site are automatically moderated through our Spam protection systems. Please be patient if your comment isn’t immediately available. We’re not trying to censor you, the system just wants to make sure you’re not a robot posting random spam.

This website thrives because of its community. While we support lively debates and understand that people get excited, frustrated or angry at times, we ask that the conversation remain civil. Racism, to include any religious affiliation, will not be tolerated on this site, including the disparagement of people in the comments section.

[dipl_ajax_search search_placeholder=”Article Search” display_fields=”on|on|off|off” search_result_box_bg_color=”#870404″ search_icon_font_size=”20px” search_icon_color=”#870404″ loader_color=”#870404″ _builder_version=”4.17.4″ _module_preset=”default” search_result_item_title_font_size=”14px” search_result_item_excerpt_font_size=”11px” border_color_all_form_field=”#870404″ global_colors_info=”{}”][/dipl_ajax_search]

[the_ad_group id=”30343″]

[the_ad_group id=”30344″]

[620studio_custom_posts post_type=”report” columns=”1″ limit=”1″ category_id=”23503″ caption=”no” date=”no” title=”no”]